Stock-Based Compensation

$689.10M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$689.10Mperiod endingJun 30, 2026

VRTX Stock-Based Comp ($0.00 → $689.10M)

Annual stock-based compensation

High-resolution chart · PNG

VRTX stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	685,900,000
Dec 31, 2024	698,500,000
Dec 31, 2023	581,200,000
Dec 31, 2022	491,300,000
Dec 31, 2021	441,400,000
Dec 31, 2020	429,500,000
Dec 31, 2019	360,489,000
Dec 31, 2018	325,047,000
Dec 31, 2017	290,736,000
Dec 31, 2016	237,705,000
Dec 31, 2015	231,025,000
Dec 31, 2014	177,542,000
Dec 31, 2013	127,303,000
Dec 31, 2012	114,285,000
Dec 31, 2011	126,751,000
Dec 31, 2010	97,676,000
Dec 31, 2009	86,722,000
Dec 31, 2008	63,012,000
Dec 31, 2007	59,407,000
Dec 31, 2006	39,137,000
Dec 31, 2005	7,530,000
Dec 31, 2004	4,165,000
Dec 31, 2003	3,146,000
Dec 31, 2002	1,501,000
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0